Here are relevant reports on : ai-in-stem-education-market
-
Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Beads (Natural (Collagen), Synthetic (Polystyrene)), Application (Vaccine, CGT, Stem Cells) - Global Forecast to 2029
The global microcarriers market, valued at US$2.03B in 2023, is forecasted to grow at a 8.0% CAGR, reaching US$2.08B by 2024 and US$3.05B by 2029. Market growth is attributed to rising investments in cell & gene therapy research, growing preference for single-use technologies, and increasing R&D spending for biopharmaceutical production.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Emotion AI Market by Solutions (Emotion Recognition, Emotion AI SDKs and APIs, Emotion Analytics), Type (Text-Focused, Voice-Focused, Video & Multimodal), Technology (Machine Learning, NLP, Computer Vision) - Global Forecast to 2030
The Emotion AI market is projected to reach USD 9.01 billion by 2030, at a CAGR of 21.9% during the forecast period. The report profiles key players such as IBM (US), Microsoft (US), Google (US), Amazon (US), Smart Eye (Sweden), Entropik Tech (India), Uniphore (US), Audeering GmbH (Germany), VIER GmbH (Germany), Cognitec (Germany), Symanto (Germany), Realeyes (UK), CIPIA Vision (Israel), Noldus (Netherlands), Cogito (US), Morphcast (US), Voicesense (Israel), Superceed (Malaysia), Siena AI (US), Opsis (Singapore), Behavioral Signals (US), Hume (US), Kairos (US), Beemotion.AI (Australia), Intelligent Voice (UK), Davi (France), Utrigg (Ukraine), AttentionKart (India) and VERN AI (US).
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) & Region - Global Forecast to 2028
The global stem cell therapy market, valued at US$259 million in 2022, stood at US$286 million in 2023 and is projected to advance at a resilient CAGR of 16.5% from 2023 to 2028, culminating in a forecasted valuation of US$615 million by the end of the period. Market growth is driven mainly by factors such as rise in funding for stem cell research, upsurge in the number of cell therapy production facilities that have GMP certification, and increased in the number of clinical trials associated with stem cell therapies.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Biopreservation Market by Product (Media [Cryopreservation, Hypothermic]), Equipment (Freezers, Refrigerators, Incubators, Centrifuge, Accessories), Biospecimen (Tissues, Organs, Stem Cells), Application (Research, Therapeutic) - Global Forecast to 2029
The global biopreservation market, valued at US$3.7 billion in 2022, stood at US$4.4 billion in 2024 and is projected to advance at a resilient CAGR of 9.8% from 2024 to 2029, culminating in a forecasted valuation of US$7.1 billion by the end of the period. The market will grow as a result of growing advancements in the biobanks and increase in the trend of preserving newborn cord blood stem cells and rise in the need for personalized medicines.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) & Region - Global Forecast to 2027
The global nerve repair market growth is primed to transition from $6.5 billion in 2022 to $11.6 billion by 2027, showcasing a strong CAGR of 12.1%. This growth is driven by the increasing prevalence of neurological disorders, rising geriatric population, high incidence of nerve injuries, and government support for neurological research.
- Published: May 2022
- Price: $ 4950
- TOC Available:
-
Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada), Europe, APAC, RoW) - Global Forecast to 2028
The market size for synthetic stem cells is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period. The ethical concerns on the use of embryonic stem cells and the risk of tumor formation and immune response to natural stem cells are the key factors driving the growth of this market. The key developers of synthetic stem cell technology are North Carolina State University (NCSU) (US) and Zhengzhou University (China).
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Cell Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal, Microbial), Application (Basic Research, Stem Cell, Discovery & Development) - Global Forecast to 2023
The global cell viability assays market is projected to reach USD 4.16 billion by 2023, growing at a CAGR of 8.4%. The prominent players in the cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Apoptosis Assays Market by Product (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence microscopy), Application (Stem Cell, Discovery & Development, Clinical Research) & Region - Global Forecasts to 2023
The global apoptosis assays market is projected to reach USD 5.9 billion by 2023, at a CAGR of 10.5%. The prominent players in the apoptosis assays market are Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), GE Healthcare (US), Sartorius AG (Germany), Danaher Corporation (US), Geno Technology (US), GeneCopoeia, Inc. (US), Bio-Techne Corporation(US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), and Creative Bioarray (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
Animal Stem Cell Therapy Market by Type (Allogeneic, Autologous), Species (Dog, Cat & Horse), End User (Veterinary Hospital, Research Organization) - Global Forecast to 2027
The global animal stem cell therapy market size is projected to reach USD 0.3 billion by 2027 from USD 0.2 million in 2022, at a CAGR of 5.2% during the forecast period. The growth in the cases of various health issues such as arthritis, degenerative joint disorders, and tendon injuries in animals. This factor is encouraging the development of the global animal stem cell therapy market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
US Generative AI Market by Software (Foundation Models, Model Enablement & Orchestration Tools, Gen AI SaaS), Modality (Text, Code, Video, Image, Multimodal), Application (Content Management, BI & Visualization, Search & Discovery) - Forecast to 2032
The US generative AI market size is projected to grow from USD 25.78 billion in 2025 to USD 279.44 billion by 2032, at a CAGR of 40.6% during the forecast period.The Key Players include IBM (US), NVIDIA (US), OpenAI (US), Anthropic (US), Meta (US), HPE (US), AMD (US), Oracle (US), Innodata (US), iMerit (US), Salesforce (US), Telus Digital (US), Microsoft (US), Google (US), AWS (US), Adobe (US), Certific (US), Fractal Analytics (US), Tiger Analytics (US), Quantiphi (US), Databricks (US), Dialpad (US), Simplified (US), Hugging Face (US), Persado (US), Copy.AI (US), Synthesis AI (US), Hypotenuse AI (US), Together AI (US), Adept (US), Writesonic (US), Inflection AI (US), Jasper (US), Runway (US), Inworld AI (US), Typeface (US), H2O.ai (US), Speechify (US), Midjourney (US), FireFiles (US), Forethought (US), Character.AI (US), Cursor (US), DeepSeek (US), XAI (US), Abridge (US), Perplexity AI (US), SambaNova (US), Scale AI (US), Labelbox (US), and HQE Systems (US).
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
